down arrow

Dechra Pharmaceuticals Plc

  • Market Cap: N/A
  • Industry: Pharmaceuticals: Major
  • ISIN: GB0009633180
GBP
38.66
0.02 (0.05%)

Jan 15

LON

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
ECO Animal Health Group Plc
Shield Therapeutics Plc
Alliance Pharma Plc
Arecor Therapeutics Plc
Redx Pharma Plc
Indivior PLC
Destiny Pharma Plc
GSK Plc
AstraZeneca PLC
Benchmark Holdings Plc
Dechra Pharmaceuticals Plc
Why is Dechra Pharmaceuticals Plc ?
Icon
Unrated Stock - No Analysis Available
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals: Major)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Icon
No Data Found
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
13.34%
EBIT Growth (5y)
18.74%
EBIT to Interest (avg)
7.09
Debt to EBITDA (avg)
1.36
Net Debt to Equity (avg)
0.55
Sales to Capital Employed (avg)
0.61
Tax Ratio
23.30%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
9.02%
ROE (avg)
8.88%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
59
Industry P/E
Price to Book Value
5.83
EV to EBIT
51.07
EV to EBITDA
26.19
EV to Capital Employed
4.11
EV to Sales
6.33
PEG Ratio
NA
Dividend Yield
32.32%
ROCE (Latest)
8.05%
ROE (Latest)
9.81%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
Bearish
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
No Trend
Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

Icon
Not enough Data to analyse Financial Trend
Icon
Not enough Data to analyse Financial Trend
Here's what is working for Dechra Pharmaceuticals Plc
Net Sales
Highest at GBP 384.1 MM and Grown
In each period in the last five periods
MOJO Watch
Near term sales trend is very positive

Net Sales (GBP MM)

Raw Material Cost
Fallen by -2.23% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Dechra Pharmaceuticals Plc
Pre-Tax Profit
At GBP 24.3 MM has Fallen at -44.65%
Year on Year (YoY)
MOJO Watch
Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (GBP MM)

Interest Coverage Ratio
Lowest at 614.49
in the last five periods
MOJO Watch
The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Inventory Turnover Ratio
Lowest at 2.05% and Fallen
In each half year in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Interest
Highest at GBP 13.8 MM
in the last five periods and Increased by 48.39% (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (GBP MM)

Operating Profit
Lowest at GBP 84.8 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is negative

Operating Profit (GBP MM)

Operating Profit Margin
Lowest at 22.08 %
in the last five periods
MOJO Watch
Company's profit margin has deteriorated

Operating Profit to Sales

Pre-Tax Profit
Lowest at GBP 24.3 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (GBP MM)

EPS
Lowest at GBP -0.45
in the last five periods
MOJO Watch
Declining profitability; company has created lower earnings for shareholders

EPS (GBP)

Cash and Eqv
Lowest at GBP 74.4 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is deteriorating

Cash and Cash Equivalents

Debt-Equity Ratio
Highest at 56.95 %
in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Debtors Turnover Ratio
Lowest at 4.78%
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Dividend per share
Lowest at GBP 4.78
in the last five years
MOJO Watch
Company is distributing lower dividend than previous years

DPS (GBP)

Dividend Payout Ratio
Lowest at 0%
in the last five years
MOJO Watch
Company is distributing lower proportion of profits generated as dividend

DPR (%)

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."